Mundipharma is a member of a global network of independent associated companies which are engaged in research, development, production and marketing of prescription medicines and consumer healthcare products. Established as a leader in the development and provision of medicines for pain, we have expanded our portfolio to include treatments for cancer, glaucoma, asthma, burns, wounds as well as skin irritations.

For more information, visit

Responsible prescribing of opioids for chronic non-cancer pain as part of a multimodal approach

Non-drug and non-opioid therapies should be implemented as the first-line approach to care in patients with chronic non-cancer pain. Only when these approaches have been ineffective, opioid therapies may be considered in a select group of patients as outlined in current Australian guidelines. This module aims to educate GPs about the broad issues about opioid use in society, as well as how to confidently and responsibly manage chronic non-cancer pain using an individualised sociopsychobiomedical approach.